Delivery Order SPE2DB22D3011-SPE2DB24FQ2AA
- Not listed
- This federal contract award, valued at $1,586.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of MISOPROSTOL 200 MCG TABLET UD 100S, a pharmaceutical product. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This federal contract award is for $3,192.04 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the U.S. government. The contract is a delivery order with a firm fixed price, awarded by the Defense Logistics Agency (DLA) to provide Mesalamine DR 1.2 GM Tablet 120S. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of 60 tablets of Diclofenac-Misoprost 50-0.2 mg. It has a firm fixed price of $1,048.55 and a completion date of September 23, 2024. This order is not set aside for any specific business type. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous contracts by various federal...
- The U.S. government has awarded a Firm Fixed Price Delivery Order contract valued at $22,491.00 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which does not have a set-aside designation, is to provide a wide range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical, in support of the Department of Defense (DoD) worldwide. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA valued up to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $2,371.64, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of a variety of pharmaceutical products and medical supplies, including prescription medications, over-the-counter drugs, and critical care materials such as syringes and test kits. This contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation....
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $2,974.38 Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of a wide range of pharmaceutical products and medical supplies, including prescription medications, over-the-counter drugs, and critical care materials such as syringes and test kits. This contract is not set aside for any particular business type....
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a firm-fixed-price delivery order valued at $2,467.19. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to provide pharmaceutical products and medical supplies. The contract has no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, is providing a diverse range of prescription...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,594.32 Firm Fixed Price Delivery Order contract is for the supply of MESALAMINE DR 1.2 GM TABLET 120S, with a completion date of April 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The U.S. government awarded a $25,516.98 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. The contract is to supply a variety of pharmaceutical products and medical supplies, including...
- This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $40,550.62, is a delivery order with a firm fixed price and was awarded by the Defense Logistics Agency (DLA) Medical Supply Chain, a part of the Department of Defense. The contract is for the provision of a variety of pharmaceutical and medical products, including prescription medications,...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FQ2AADelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $2,264.14 firm fixed price delivery order for the supply of 4564912456 - Misoprostol 100 MCG Tablet UD 100S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 6/14/24 |